By Anil Oza
Sept. 16, 2026
A coalition of 17 researchers—comprising 13 named plaintiffs and four anonymous whistleblowers—has launched a significant class-action lawsuit against the National Institutes of Health (NIH). The litigation alleges that the federal agency has engaged in a systematic infringement of First Amendment rights by utilizing algorithmic screening tools to purge grant applications of specific terminology deemed ideologically unfavorable by the current administration.
The lawsuit, which seeks to halt the use of these "verboten" keyword filters, carries implications that extend far beyond the plaintiffs. If the court certifies the class and rules in favor of the researchers, the decision could dismantle the current administrative mechanism governing how billions of dollars in biomedical funding are allocated, potentially forcing a radical restructuring of NIH oversight.
The Core Allegation: Algorithmic Censorship
At the heart of the complaint is the assertion that the NIH has shifted from its traditional mandate of scientific inquiry toward a politically motivated "viewpoint-based" screening process. According to the filing, the agency has deployed sophisticated computational text analysis tools to flag and subsequently reject or force the alteration of research proposals containing specific terminology.
The primary targets of this scrutiny include research into health disparities, vaccine efficacy, climate change, and efforts to foster diversity within the biomedical workforce. Plaintiffs argue that by forcing scientists to "renegotiate" their titles and abstracts—effectively scrubbing terms such as "equity," "racism," "disparity," and "discrimination"—the NIH is not merely managing a budget; it is actively shaping the language of science to conform to a specific executive agenda.
A Chronology of Institutional Overreach
The current crisis follows a turbulent two-year period during which the federal government attempted to fundamentally reshape the landscape of American biomedical research.
The Era of Mass Terminations (2025)
When the Trump administration took office, it initiated a series of aggressive cuts, terminating wide swaths of federally funded research. The goal, as described by internal policy documents, was to align the NIH’s portfolio with the administration’s core priorities. However, this "slap-dash" approach faced immediate legal backlash.
In June 2025, federal judge William Young ruled that the abrupt terminations violated the Administrative Procedures Act (APA), which mandates rigorous, transparent processes for agency policy changes. While hundreds of grants were subsequently reinstated, the ruling did not fully restore the scientific landscape, as many researchers—like Dr. Arghavan Salles—found their funding permanently severed despite the court’s intervention.
The Shift to "Renegotiation" (2025–2026)
Following the judicial rebuke of mass terminations, the agency pivoted to a more subtle, yet arguably more pervasive, strategy. Rather than outright denial, the NIH began "renegotiating" existing and pending grants.
By late 2025, the impact was stark: over 700 grantees had altered their project titles to comply with the agency’s unwritten linguistic standards. By 2026, the use of computational tools to automate this filtering process became standard operating procedure. These tools scan grant databases for "disfavored" keywords, flagging applications before they reach human review boards.
Data and Disruption: The Human Cost
The human impact of these policies is best exemplified by the experiences of the plaintiffs. For Dr. Arghavan Salles, the loss of her R01 grant—which focused on the prevalence of sexual harassment in medical training—was more than a budgetary blow; it was a professional silencing.
"I couldn’t talk about my research on implicit bias or microaggressions or sexual harassment or belonging," Dr. Salles said in an interview. "It’s really hard to demonstrate that you’re a leader in a field without being able to use the very words that describe that field and that work."
Similarly, Dr. Michael Green, a social epidemiologist at Johns Hopkins University, saw his career trajectory stalled. Initially lauded for his work on how discrimination impacts the cardiovascular health of aging Black adults, Dr. Green was forced to remove "discrimination" and "Black" from his project title as he transitioned from his PhD to his postdoctoral funding.
"To this day, I haven’t received clarity on why my work was targeted," Dr. Green noted. The opacity of the process has left him disillusioned. He has since ceased applying for NIH grants entirely, citing a fundamental loss of trust in an agency he believes has abandoned the core academic tenet of open, objective inquiry.
Official Responses and Contradictions
The NIH’s public stance on these allegations has been characterized by sharp contradictions. NIH Director Jay Bhattacharya has publicly dismissed the existence of a "blacklist." In a July 2026 interview with PragerU, a conservative advocacy group, Bhattacharya stated, "I am deeply against banned word lists. I don’t believe in them. I will not have my institution embrace them."
However, court documents suggest a different reality. In a July 2026 stipulation filed in a separate lawsuit involving University of California researchers, the NIH’s head of extramural research admitted that the agency utilized "search terms, keywords, or phrases to identify and terminate grants presumed to express viewpoints… that HHS-NIH no longer wished to subsidize."
This admission serves as a cornerstone for the plaintiffs’ current case. Olga Akselrod, a senior counsel at the ACLU who represents the researchers, argues that the agency is simply engaging in a sophisticated game of "cat and mouse" with the judiciary. "NIH supplemented the directives at issue in previous litigation with a series of additional policies that purported to replace the vacated ones, but in fact just continued the viewpoint-based purge," Akselrod said.
Broader Implications for Science and Policy
The outcome of this lawsuit will likely define the boundaries of executive power over scientific research for the next decade.
Erosion of Academic Freedom
The primary implication is the potential erosion of academic freedom. When researchers must censor their own work to secure the funding necessary to conduct it, the nature of scientific inquiry changes. If specific topics are effectively off-limits, the research pipeline for critical social health issues—such as mental health, health equity, and systemic biases—may dry up.
The "Chilling Effect"
Beyond the direct impact on the plaintiffs, the "chilling effect" is already manifesting in university departments nationwide. Many junior researchers are self-censoring their proposals before they are even submitted, fearing that certain terminology will trigger an automatic rejection by the NIH’s algorithmic filters. This creates a feedback loop where entire fields of study are deemphasized by the agency, leading to a distorted view of public health priorities.
The Future of NIH Funding
If the plaintiffs prevail, the ruling could mandate a return to blind, merit-based grant evaluation, stripping the executive branch of its ability to use funding as a lever for political messaging. Conversely, a loss for the plaintiffs would establish a legal precedent that federal agencies have broad discretion to prioritize "alignment with administration priorities" over the neutral pursuit of scientific knowledge.
As the legal proceedings continue, the scientific community remains in a state of high alert. For researchers like Michael Green, the stakes are existential. "If we don’t prevail," he warned, "the bottom falls out from under the NIH. We are witnessing the slow erosion of the idea that science should be a neutral, objective pursuit of truth."
For now, the NIH remains silent, having declined to respond to requests for comment regarding the latest filing. With the case expected to move toward discovery, the internal communications of the agency—and the true extent of its algorithmic screening—will likely be brought into the harsh, public light of a federal courtroom.
